Additionally, both NAFLD-HCC and NAFLD-cirrhosis BE dampened the production of IL-4 compared to non-NAFLD control BE (P < 0.0001) (Fig. 6). Here, IL4 is linked to metabolic dysfunction-associated steatotic liver disease.